TA191: Gastric cancer (advanced) - capecitabine
This is a discussion on TA191: Gastric cancer (advanced) - capecitabine within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Gastric cancer (advanced) - capecitabine. It links to the published guidance and key ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-27-2010, 08:25 PM
|
|||
|
|||
TA191: Gastric cancer (advanced) - capecitabine
The summary for the published technology appraisal on Gastric cancer (advanced) - capecitabine. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA61: Colorectal cancer - capecitabine and tegafur uracil | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA62: Breast cancer - capecitabine (replaced by CG81) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA100: Colon cancer (adjuvant) - capecitabine and oxaliplatin | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| Sorafenib Increases Survival in Advanced Liver Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-25-2008 07:50 AM |
| Lapatinib Promising for Advanced ErbB2-Amplified Breast Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-09-2008 05:59 PM |
© 2008 DrugManagementForum™ powered by |
 |